ViroPharma Announces Lead Compound Series with Potent Antiviral Activity Against Orthopoxviruses
07 juil. 2003 07h30 HE
|
ViroPharma Incorporated
EXTON, Pa., July 7, 2003 (PRIMEZONE) -- VIROPHARMA INCORPORATED (Nasdaq:VPHM) today announced that its scientists have discovered a lead compound series from VIROPHARMA's unique chemical library that...
ViroPharma Incorporated Reports First Quarter Financial Results
07 mai 2003 08h00 HE
|
ViroPharma Incorporated
EXTON, Pa., May 7, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today its financial results for the quarter ended March 31, 2003.
For the quarter ended March 31, 2003,...
ViroPharma Announces Research Efforts Toward SARS Treatment
28 avr. 2003 09h20 HE
|
ViroPharma Incorporated
EXTON, Pa., April 28 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that its scientists are currently evaluating compounds from its chemical library for potential...
ViroPharma Incorporated Reports 2002 Financial Results
25 févr. 2003 09h20 HE
|
ViroPharma Incorporated
EXTON, Pa., Feb. 25, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today financial results for the fourth quarter and the year ended December 31, 2002.
Quarter ended December...
ViroPharma Announces the Initiation of Phase 1 Hepatitis C Trials and Updates its Product Pipeline and Convertible Notes
03 janv. 2003 09h43 HE
|
ViroPharma Incorporated
EXTON, Pa., Jan. 3, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that, together with Wyeth, it has initiated phase 1 human clinical trials with HCV 371, the lead compound...
ViroPharma Incorporated Reports Third Quarter Financial Results
29 oct. 2002 19h00 HE
|
ViroPharma Incorporated
EXTON, Pa., Oct. 29, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today financial results for the third quarter ended September 30, 2002.
For the quarter ended September 30,...
ViroPharma to Release Third Quarter Financial Results on October 30, 2002
29 oct. 2002 11h07 HE
|
ViroPharma Incorporated
EXTON, Pa., Oct. 29, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) will release its financial results for quarter ended September 30, 2002 after the market closes on Tuesday, October 29,...
ViroPharma Incorporated Reports Second Quarter Financial Results
12 août 2002 08h46 HE
|
ViroPharma Incorporated
EXTON, Pa., Aug. 12, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) reported today financial results for the second quarter ended June 30, 2002.
For the quarter ended June 30, 2002,...
Notice: ViroPharma Incorporated Teleconference Call
01 août 2002 10h01 HE
|
ViroPharma Incorporated
EXTON, Pa., Aug. 1, 2002 (PRIMEZONE) -- ViroPharma (Nasdaq:VPHM) will hold a teleconference call Thursday, August 1 at 2:30 pm (EST) to provide a further update on ViroPharma's Restructuring of...
ViroPharma Announces Restructuring of Operations
01 août 2002 10h00 HE
|
ViroPharma Incorporated
EXTON, Pa., Aug. 1, 2002 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that it has restructured its organization to establish the foundation for its future growth. As part of...